Showing posts with label swine flu. immune system. Vitamin C. Show all posts
Showing posts with label swine flu. immune system. Vitamin C. Show all posts

Wednesday, October 21, 2009

Flu Story: A Pregnant Woman’s Ordeal

The group most threatened by swine flu and most in need of the new vaccine, world health authorities agree, is that of pregnant women.

For example, Aubrey Opdyke.

On June 27, Ms. Opdyke, a 27-year-old waitress and former high-school swimmer who weighed 135 pounds before her pregnancy and had no health risks other than a smoking habit, came down with mild flu symptoms.

She finally came home from the hospital three weeks ago.

“At first, I didn’t think anything of it — just another flu bug,” Ms. Opdyke said recently. “But it really wrecked me. I probably shouldn’t have made it.”

In the four months she was hospitalized, she spent five weeks in a coma, suffered six collapsed lungs and a near-fatal seizure. High-pressure ventilation blew her up like a molten balloon until “she looked like she weighed 400 pounds,” her husband, Bryan, said, and she has stretch marks from her neck to her ankles. Her muscles and lungs are still so weak that she uses a walker.

While hospitalized, she missed seeing her 4-year-old daughter, Hope, learn to swim and start pre-school.

And, most important, she lost her baby. Parker Christine Opdyke, almost 27 weeks in the womb, was delivered by emergency Caesarean section on July 18, when her fetal heart rate plummeted during Ms. Opdyke’s third lung collapse. Her airways were too blocked to let a breathing tube in, possibly a side effect of the drugs saving her mother. She lived seven minutes.

On Oct. 1, the Centers for Disease Control and Prevention said 100 pregnant women had been in intensive care with swine flu and 28 had died. That is a tiny fraction of what are believed to have been millions of cases in the country. But it is the best argument, federal officials say, for the drawn-out, expensive effort to make a swine flu vaccine.

Pregnant women are particularly susceptible because they are in the younger age group most likely to catch this new virus, while those over 50 who have had more flus rarely catch it. Moreover, pregnancy suppresses the immune system to protect the fetus, and the growing baby makes it harder for a mother to clear her lungs.

All but a few of the pregnant women who have died or been near death from swine flu are unknown. Privacy laws prevent health departments from releasing their names, and few families come forward.

The Opdykes did because “we wanted to get it out there how dangerous it can be,” Ms. Opdyke said.

“We have friends who get flu symptoms and say, ‘Oh, I’m not going to a doctor,’ ” Mr. Opdyke added. “And we say, ‘Do you not understand what we went through?’ I can’t imagine why there’s so much nonchalance.”

That nonchalance strikes close to home.

As they said this, Ms. Opdyke was doing her daily physical therapy, struggling to lift one-pound weights. Her therapist interrupted to announce that she opposed flu shots.

“Have you ever read the labels?” she asked. “They’re so full of toxins.”

Asked if she realized that a shot, had it existed in June, might have saved her client and her baby, she frowned and went back to her clipboard.

Unlike some other families that came forward, the Opdykes are not threatening to sue anyone.

They do not blame her obstetrician, even though she suggested acetaminophen the first time Ms. Opdyke called her and prescribed an antibiotic the second.

“Swine flu just wasn’t on our minds at all,” Ms. Opdyke said.

Nor are they angry at the Wellington Regional Medical Center. “I don’t think if I’d taken her anywhere else, she would have survived,” Mr. Opdyke said.

Her flu came on gradually, and she never had a high fever. But after a week of feeling exhausted and achy, she became delirious. When Mr. Opdyke drove her to the hospital, with his finger on the door-lock button for fear she would jump out, she could not tell the triage nurse her name.

Her blood oxygen level was below 70; normal is 95, and below 80 is life-threatening. Both lungs were full of fluid.

Thrashing, she knocked off oxygen masks and pulled out an intubation tube. Panic made her hyperventilate. Doctors finally sedated her into a paralytic coma to let the ventilator work.

She survived near-failure of her kidneys, then her lungs, damaged by continuous high-pressure oxygen, began collapsing. Mr. Opdyke was warned he might have to choose — her life or that of the baby, who was just at the border of survivability outside the womb.

“I said, ‘Save Aubrey,’ ” he said of the woman he married last year. “I can make another baby, but I can’t replace her.”

Her third lung collapse forced the issue. Parker had to be delivered, but she did not survive.

Now I Lay Me Down to Sleep, a photographers’ charity for families of premature infants, offered to take black-and-white pictures. Ms. Opdyke’s mother bathed Parker and brushed her hair.

“Some people don’t agree,” Mr. Opdyke said about having the photographs taken. “But for me there was no option. Aubrey wasn’t awake, she didn’t get to bond. If I didn’t do it, there’s no way I could make it up to her.”

Aubrey Opdyke started to recover, then developed a bacterial infection common to ventilator patients. She nearly succumbed, then rallied and doctors started to wean her off the coma-inducing drugs. She had weeks of hallucinations about a friendly white dog visiting her but could not ask about it because of the tube.

Mr. Opdyke took comfort from what he saw as divine signs. Dog is “God” backwards, he noted. And one day, in a panic because he had forgotten to wear his wife’s wedding ring around his neck, he saw a license plate reading “FAITH.”

Ms. Opdyke’s last crisis was a still-unexplained seizure during a family visit. Her mother had been painting her nails and blamed herself, thinking the fumes had done it.

Now that she is home, in the townhouse complex they rent near the West Palm Beach airport, Ms. Opdyke is struggling to regain her strength. Muscles atrophy into rubber bands; every day in a coma means two days’ recovery.

She apologizes for the messy yard; she would pick it up but barely has the strength to get upstairs to bed. Mr. Opdyke has gone back part-time to his job at UPS.

Mr. Opdyke worries he gave her the flu. “I was sick two weeks before,” he said. “I touch packages that have been touched a thousand times. If anybody’s going to catch it, it’s me.”

He said he had not yet looked at the bills. His insurance covered most, he said, “but it had to be over a million, and we owe 20 percent; I’m not ready for that many commas.”

Friends from their jobs and a Girl Scout charity that Ms. Opdyke once ran with her mother have raised over $10,000 by holding benefits, and small checks have come in after articles by local journalists. “It’s a lot of help,” Ms. Opdyke said. “It really shows the compassion of people.”

And does she want another baby?

“Yes,” she says firmly. “At first, I didn’t. Now I do. But I’ve got to get my strength back.”


P.S. Boost your immune system by eating Vitamin C & Vitamin D rich Foods and Fruits.



source

Sunday, October 11, 2009

H1N1 Influenza Vaccine Trial in People with Asthma

NIH prepares to launch 2009 H1N1 influenza vaccine trial in people with asthma.

The National Institutes of Health is preparing to launch the first government-sponsored clinical trial to determine what dose of the 2009 H1N1 influenza vaccine is needed to induce a protective immune response in people with asthma, especially those with severe disease. The study is cosponsored by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Heart, Lung, and Blood Institute (NHLBI), both part of NIH.

"People with severe asthma often take high doses of glucocorticoids that can suppress their immune system, placing them at greater risk for infection and possibly serious disease caused by 2009 H1N1 influenza virus," says NIAID Director Anthony S. Fauci, M.D. "We need to determine the optimal dose of 2009 H1N1 influenza vaccine that can be safely administered to this at-risk population and whether one or two doses are needed to produce an immune response that is predictive of protection."

The study plan has been submitted to the Food and Drug Administration for review. With FDA allowing it to proceed, the clinical trial will be conducted at seven sites across the United States that participate in NHLBI's Severe Asthma Research Program.

This program already has a well-characterized group of participants with mild, moderate or severe asthma who may be eligible for this new study. These groups are largely distinguished by the amount and frequency of glucocorticoids needed to control asthma symptoms. People with mild disease may not need glucocorticoids, or may require low doses of inhaled glucocorticoids; those with moderate asthma need low to moderate doses of inhaled glucocorticoids; and those with severe asthma need high doses of inhaled glucocorticoids and frequently use oral glucocorticoids as well.

Individuals who already have been infected with 2009 H1N1 influenza or have received a 2009 H1N1 influenza vaccination will not be eligible for the study.

"The results of this study will have immediate implications for individuals with severe asthma as well as those who have milder asthma," says NHLBI Director Elizabeth G. Nabel, M.D.
Early results from other clinical trials of 2009 H1N1 influenza vaccines in healthy adults have shown that a single 15-microgram dose of 2009 H1N1 influenza vaccine without adjuvant is well tolerated and induces a strong immune response in most participants. The same vaccine also generates an immune response that is expected to be protective in healthy children ages 10 to 17 years. Ongoing trials are comparing the immune response to one and two doses of 15- or 30-micrograms of vaccine given three weeks apart in various populations.

The Centers for Disease Control and Prevention has recommended that certain at-risk populations receive the new H1N1 vaccine as a priority before the general population. These target populations include pregnant women, health care providers and individuals with underlying chronic medical conditions, including asthma.

People who have severe asthma may be particularly at risk for infection with the 2009 H1N1 influenza virus. A report published in 2004 suggested that some people who took high doses of glucocorticoids to treat their asthma may receive less protection from influenza vaccines against some strains of influenza. Early in the 2009 H1N1 flu outbreak a CDC review of hospital records found that people with asthma have a four-fold increased risk of being hospitalized with infection compared to the general population.

The study will enroll approximately 350 people with mild, moderate and severe asthma. Participants will be organized into two groups: those with mild or moderate asthma and those with severe asthma. Half of the participants in each group will receive a 15-microgram dose of vaccine, and the other half a 30-microgram dose. Three weeks later, each participant will receive a second dose of the same amount. The strength of the immune response induced by the vaccine will be determined in blood samples by measuring the level of antibodies against 2009 H1N1 flu virus.

Safety data will be collected and examined throughout the course of the study by trial investigators and by an independent safety monitoring committee. Participants will be monitored for any side effects they may experience because of the vaccine, as well as asthma attacks that occur during the study period.

The vaccine to be used in the trial, manufactured by Novartis, contains inactivated 2009 H1N1 influenza virus and therefore cannot cause anyone to become infected with the virus.

The trial will be conducted at the following locations:
Cleveland Clinic, Ohio
Emory University, Atlanta
University of Pittsburgh Asthma Institute
University of Virginia, Charlottesville
University of Wisconsin, Madison
Wake Forest University, Winston-Salem, N.C.
Washington University School of Medicine, St. Louis

Detailed information about this study can be found on the ClinicalTrials.gov Web site at http://clinicaltrials.gov/ct2/results?term=H1N1+AND+asthma.

Additional information about NIAID-sponsored clinical trials of candidate H1N1 vaccines can be found here: Clinical Trials of 2009 H1N1 Influenza Vaccines Conducted by the NIAID-Supported Vaccine and Treatment Evaluation Units

(http://www3.niaid.nih.gov/news/QA/vteuH1N1qa.htm); Pediatric Trials of Candidate 2009 H1N1 Vaccine at NIAID Vaccine and Treatment Evaluation Units (VTEUs)

(http://www3.niaid.nih.gov/news/QA/qaH1N1pedvax.htm); NIAID Launches 2009 H1N1 Influenza Vaccine Trial in Pregnant Women

(http://www3.niaid.nih.gov/news/QA/H1N1pregnanttrials.htm); NIH Launches 2009 H1N1 Influenza Vaccine Trial in HIV-Infected Pregnant Women: Trial in HIV-Infected Children, Youth to Begin Next Week

(http://www3.niaid.nih.gov/news/newsreleases/2009/H1N1HIVTrials.htm).
Visit www.flu.gov for one-stop access to U.S. government information on avian and pandemic influenza.

Also, visit NIAID's Web sites for more information about flu(http://www3.niaid.nih.gov/topics/Flu/) and asthma (http://www3.niaid.nih.gov/topics/asthma/) and NHLBI's Web site for more information about asthma (http://www.nhlbi.nih.gov/health/dci/Diseases/Asthma/Asthma_WhatIs.html) .

For additional information about the NHLBI's Severe Asthma Research Program, contact the NHLBI Office of Communications at (301) 496-4236 or e-mail nhlbi_news@nhlbi.nih.gov.

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at www.niaid.nih.gov.

Part of the National Institutes of Health, the National Heart, Lung, and Blood Institute (NHLBI) plans, conducts, and supports research related to the causes, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases; and sleep disorders. The Institute also administers national health education campaigns on women and heart disease, healthy weight for children, and other topics. NHLBI press releases and other materials are available online at www.nhlbi.nih.gov.

The National Institutes of Health (NIH)—The Nation's Medical Research Agency—includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.



source

Monday, September 28, 2009

New swine flu wave hits Mexico, closings unlikely


Looks like the dreaded Swine Flu is here to stay. The next wave of swine flu has arrived, and Mexicans are bracing for an outbreak that may be even larger than the one here last spring that became a pandemic.

Daily diagnoses reached higher levels in September than the H1N1 peak in April, with 483 new cases in just one day this month alone.

It's unlikely there will be large-scale closings of schools and stadiums, however, because health officials know the virus is usually mild if treated early.

"We know the situation is not as serious" as officials feared last spring, said Health Secretary Jose Angel Cordova.

Still, 3,000 schools across Mexico were closed earlier this week as a result of the virus. That number has dropped to 128, Education Secretary Alonso Lujambio told senators Wednesday, as he said officials are still developing the criteria they will use to shut down schools in the future.

When the first cases of swine flu were confirmed in late April, Mexico's government immediately ordered the closure of all schools, museums, libraries and theaters in the capital. Within days, schools nationwide, restaurant dining rooms and other businesses shut down, streets mostly emptied and soldiers handed out millions of face masks.

Mexico could see up to 5 million cases of swine flu during this winter's flu season and deaths could reach 2,000, Cordova said.

Some hospitals already have the same number of swine flu patients as they had in April, he said Thursday. Officials are negotiating with laboratories to secure doses of a vaccine by October, he added.

Mexico had 29,417 reported cases and 226 deaths as of Friday.

The World Health Organization says more than 300,000 cases of H1N1 have been confirmed throughout the world, and more than 3,900 people have died from the virus.


P.S. Boost your immune system with Vitamin C rich foods and fruits.



source

Friday, September 25, 2009

Objections over swine flu vaccine


THE OBJECTIONS

Some are suspicious of the new vaccine because the government's swine flu vaccine in 1976 caused some people to contract Guillain-Barré syndrome, a sometimes deadly nervous-system disorder. (They are different vaccines based on two different viruses).

Others see this as an issue of workers' rights, that the government should not be allowed to require vaccinations.


SHUNNING THE VACCINE

Several groups are opposed to vaccination of any kind, often citing philosophical reasons. Here is a look at some of the vaccine objectors.

Some health care workers are opposed to mandatory vaccination, but not to all vaccines.

Parents of children with autism spectrum disorders have long objected to vaccinations, based on the widely disputed notion that autism-related conditions are caused by vaccines and vaccine additives.

People with allergies to eggs oppose flu shots because eggs are used in vaccine production.



source

Flu Can Raise Chances of Heart Attack



People suffering from the flu may be at higher risk for having a heart attack, especially those with heart disease and diabetes, British researchers report.

Because both seasonal and the pandemic H1N1 swine flu are circulating this fall and winter, people at risk for heart attacks are urged to get a seasonal flu shot and an H1N1 flu shot, which may reduce the chance of getting the flu and thereby lower the risk for a heart attack, experts say.

"Influenza is most concerning because of its secondary complications," said Dr. Marc Siegel, an associate professor of medicine at New York University School of Medicine in New York City.

"Most of the time with influenza, death or hospitalization isn't because of the influenza, it's because influenza puts you in a weakened state -- it's a stress on the system," he said. "So, it is not surprising that you would have the increased risk of a myocardial infarction during or right after an influenza infection."

In addition, the flu virus may have a negative effect directly on the heart, Siegel said. "Flu stresses and strains the system," he added.

To determine the risk of heart attack among those with flu, a research team led by Andrew C. Hayward, a senior lecturer in infectious disease epidemiology at the UCL Centre for Infectious Disease Epidemiology in London, looked at 39 studies conducted between 1932 and 2008.

The studies showed an increase in deaths from heart disease and more heart attacks during flu season. In fact, excess deaths because of heart disease averaged 35 percent to 50 percent, according to the report in the October issue of The Lancet Infectious Diseases.

But the studies also showed that getting a flu shot reduced the risk of dying from heart disease or suffering a heart attack, Hayward's group found.

"We believe influenza vaccination should be encouraged wherever indicated, especially in those people with existing cardiovascular disease. Further evidence is needed on the effectiveness of influenza vaccines to reduce the risk of cardiac events in people without established vascular disease," Hayward's team concluded.

Dr. Gregg C. Fonarow, a professor of cardiology at the University of California, Los Angeles, agreed that flu shots appear to reduce the risk of heart attacks.

"It has long been hypothesized that influenza infection results in an acute inflammatory response that can also trigger the onset of cardiovascular events such as heart attack and stroke in vulnerable individuals," Fonarow said.

A number of observational studies have suggested more cardiovascular events occur in patients with influenza than otherwise expected and that individuals who receive annual flu shots are much less likely to have fatal or nonfatal cardiovascular events or be hospitalized for heart failure, he said.

"Guidelines from the American Heart Association and American College of Cardiology strongly recommend that all individuals with cardiovascular disease receive annual influenza vaccination," Fonarow said.

However, Dr. Pascal James Imperato, dean and distinguished service professor at the School of Public Health at the State University of New York Downstate Medical Center in Brooklyn, said the role of flu shots in preventing heart attack has not been proven conclusively.

"The role of severe respiratory infections in precipitating myocardial infarctions in vulnerable individuals is well-established," Imperato said. "However, the role of influenza vaccines in protecting such individuals is less clear from the limited scientific evidence available."

Sunday, September 20, 2009

U.S. to Donate 10 Percent of Swine Flu Vaccine to WHO


The United States plans to donate 10 percent of its supply of pandemic H1N1 influenza vaccine to the World Health Organization for use in low-income countries.

The nation has on order 195 million doses of the swine flu vaccine, which is due to start arriving early next month. The White House said it "is taking this action in concert" with eight other countries.

The White House released no details about the program, such as timetables and total amounts of vaccine to be donated. Officials at the Geneva-based WHO did not respond to phone and e-mail inquiries.

The other countries making donations are Australia, Brazil, Britain, France, Italy, New Zealand, Norway and Switzerland.

Earlier this summer, two vaccine manufacturers, Sanofi Aventis and GlaxoSmithKline, said they would donate 150 million doses of pandemic vaccine to WHO. Global production, by about 20 makers in all, is projected to be 2 billion to 4 billion doses over a year.

The number of people who could be protected is uncertain. The first tests of the pandemic vaccine showed that adults will need only one shot, not two as some experts predicted. Children, however, are likely to need two.

"The United States recognizes that just as this challenge transcends borders, so must our response. We invite other nations to join in this urgent global effort," the White House said.

The statement noted as well that "we remain confident that the United States will have sufficient doses of the vaccine to ensure that every American who wants a vaccine is able to receive one."

WHO officials have grappled all summer with how to prevent virtually all the supply of vaccine and antiviral drugs from going to rich countries, leaving poor countries unprotected.

"Improving access to vaccine is the central global issue at this time," Keiji Fukuda, WHO's assistant director general, told epidemiologists and influenza researchers in Washington this week. They were meeting at the Institute of Medicine to discuss events of the first five months of the pandemic.

Negotiations between WHO, the United Nations, vaccine manufacturers and wealthy countries that have standing orders for an essentially limitless supply of pandemic flu vaccine have been "slow and time-consuming," Fukuda said.

Without them "the least developed countries are not really going to have a chance of getting the vaccine." But he acknowledged that "nobody expects the numbers to work out in this pandemic."

Fukuda said that "prolonged ad hoc negotiations" like the ones this summer would be unrealistic in a pandemic more severe than this one.

In 2007, when researchers complained that Indonesia was not making samples of H5N1 "bird flu" available for study, WHO convened intergovernmental negotiations to try to reach an agreement for sharing both virus samples and the benefits that might result from them, such as vaccines. The negotiations ended this year without a full agreement.


P.S. boost your immune system thru Vitamin C nutrition.



source

Friday, September 11, 2009

Swine flu vaccine expected to arrive in October


More than a million doses of swine flu vaccine a week are expected to start rolling in next month, state health officials said Thursday, but the first batches probably won't be enough to vaccinate everyone considered most at risk.

Texas will receive 1.1 million doses of the vaccine a week for three weeks and 1.5 million a week after that, said James Zoretic, regional medical director for the Texas Department of State Health Services.

A department spokesman said the first shipments could arrive as soon as early October – though no date is yet certain.

The numbers were released at a regional pandemic influenza conference in Arlington, attended by state and local health officials.

Also on Thursday, U.S. and Australian researchers announced findings that one shot of the vaccine, rather than two, should adequately protect adults from the disease.

The H1N1 vaccine, which is different from the one for seasonal flu, will be distributed to hospitals and clinics with guidelines to inoculate priority population groups – pregnant women, people 6 months to 24 years old, and those ages 64 or younger who have certain medical conditions, among others.

Several counties, including Dallas and Tarrant, have stopped counting cases of swine flu. Instead, health officials monitor emergency room reports of fevers, coughs and sore throats to gauge the disease's spread.

So far, such reports are up about 5 percent over the same period last year – a "slight uptick," said John Carlo, medical director for Dallas County Health and Human Services.

He said officials will be carefully watching that number to see if it increases over the flu season.

Officials are also monitoring school absentee rates for signs of classroom outbreaks. So far, those numbers are "fluctuating" quite a bit, said Carlo.

He cautioned that erratic absentee rates are not unusual for the beginning of the school year.


source

Monday, September 7, 2009

A(H1N1) deaths in RP now at 28, says report


MANILA, Philippines—The number of fatalities in the Philippines due to the Influenza A(H1N1) virus has reached 28 as of Sept. 3, the Trade Union Congress of the Philippines (TUCP) said Sunday, citing a report from the Stockholm, Sweden-based European Center for Disease Prevention and Control (ECDC).

In a statement, TUCP secretary general Ernesto Herrera said the ECDC’s daily update on the A(H1N1) pandemic as of Sept. 3 stated that “20 new fatal cases have been reported in the Philippines since the country last accounted for only eight deaths on July 29.”

The ECDC’s daily updates offer statistics of A(H1N1) confirmed cases and deaths in countries and territories belonging to the European Union and/or covered by the European Free Trade Agreement. The number of deaths for selected countries, including the Philippines and seven other Southeast Asian countries, was included in the report.

There were no figures for cases in non-European countries and territories.

Herrera pointed out that the statistics on the non-European countries were based by the ECDC on “official information provided by national public health websites, or through other official communication channels.”

The daily updates may be viewed at the ECDC website (http://ecdc.europa.eu/en/healthtopics/Pages/Pandemic_%28H1N1%29_2009_Daily_Update.aspx). The Inquirer checked the latest posted daily report, dated Sept. 5, which still placed the number of fatalities in the Philippines at 28.

Figure could be higher

The former senator expressed concern that the actual number of A(H1N1) deaths in the country could possibly be higher than reported. He noted that Thailand and Malaysia, which both have superior surveillance of the disease, have already reported dozens of deaths.

The ECDC’s latest daily update listed a total of 262 confirmed A(H1N1) deaths in Southeast Asia, broken down as follows: Thailand, 130; Malaysia, 73; the Philippines, 28; Singapore, 17; Indonesia, 10; Vietnam, two; and Brunei and Laos, one each.

Globally, the ECDC said A(H1N1) had already claimed a total of 3,315 lives, according to the ECDC report.

The TUCP has been urging corporations to adopt “workplace continuity plans” to assure workers “the least possible interruption to their jobs and income” as the virus spreads more aggressively.

Weekly disclosure

Herrera also earlier urged the Department of Health (DoH) to resume its weekly disclosure of confirmed A(H1N1) cases “to keep the public in an elevated state of readiness” in dealing with the potentially faster spread of the virus. He cited the need to put “everyone in a constant high state of alertness, particularly in avoidance.”

The DoH recently ceased testing and reporting individual cases of A(H1N1), after the World Health Organization (WHO) stopped compelling countries to do so.

On Sunday, Herrera urged the DoH to consider routinely divulging to the public “at least the number of A(H1N1) cases admitted to hospitals and intensive care units, just like what health authorities are doing in other countries.”

Malacañang on Friday ordered the DoH to establish extra laboratories in public hospitals “to effectively manage” A(H1N1) cases. It also instructed the DoH to heighten the monitoring of the A(H1N1) virus and improve coordination with the WHO for real time exchange of information on the disease.

The WHO has warned governments around the world of an imminent surge in A(H1N1) cases. It said countries could see cases double every three to four days for several months, and “it is certain there will be more deaths.”



source

Friday, September 4, 2009

Pinay with lung problem dies of H1N1 in Bahrain



A runaway Filipina overseas worker with a pre-existing health condition was the first person reported to have died from A(H1N1) virus in Bahrain.

According to the report written by Mandeep Singh and Patrick Solomon and published online by the Gulf Daily News (GDN), OFW Jane Tamad Diale, 30, passed away in Salmaniya Medical Complex (SMC) Sunday.

The report said an extremely ill Diale was rushed to the hospital last Wednesday by an unidentified friend.

Diale’s father, Abdul Maguid Diale, reportedly requested her cousin Fatima to look for her when she came home during her vacation. Diale was traced at the SMC.

Fatima, too, was tested positive for H1N1 and is being treated and quarantined at home.

"I got the virus from the hospital but my condition was immediately detected. The doctors have told me to remain in isolation for a few days,” Fatima said in the report.

GDN was able to interview Mr. Diale who recently received photographs of his daughter who seemed to be in good health despite suffering from a lung condition.

"She had been suffering from a lung condition for several years, so when we heard she was in hospital, we thought her condition had aggravated," Mr. Diale said.

"In her latest photographs, she looked so beautiful, without a worry in the world. It was a beautiful smiling face, she looked so beautiful," her father added in the GDN report.

The last conversation he had with his daughter was around 10 days ago. He added that the family was aware that she ran away from her sponsor several months ago.

It was in 1999 when Diale went to work in Saudi Arabia for three years. Her condition started when she was working there. After that she moved to Dubai and then to Bahrain where her condition reportedly worsened.

GDN quoted SMC Infection Control head Dr. Jameela Salman as saying that people with H1N1 should not delay treatment as the virus could be fatal.

Dr. Salman said Diale could have been saved if she was treated earlier.



source

WHO - Swine Flu Deaths surge to 2,837


GENEVA — The World Health Organization says at least 625 people have been reported dead from swine flu in the last week.

The swine flu virus has caused at least 2,837 deaths since it emerged in Mexico and the United States earlier this year and developed into a full-blown global epidemic. Most of the deaths are in the Western Hemisphere.

WHO said Friday that laboratory-confirmed cases of the disease have now reached 254,206.

Spokesman Gregory Hartl says the figure far understates the actual number of cases because countries are no longer required to report each infection as the caseload is so high.

He says the number of deaths is growing proportionately to the increase in number of infected people.


source

Tuesday, September 1, 2009

Protect yourself against the swine flu with good nutrition


The swine flu is all over the news right now and leaving people in a panic wondering what can be done to protect against getting the illness. Good nutrition is a great place to start. Adding just a few foods to your diet can dramatically decrease your risk of getting the swine flu by building up your immune system.

Right now our population is overfed and undernourished. Meaning that people are filling up on nutritionally deficient foods, leaving their bodies malnourished and immune depressed. When your immune system isn’t supported with good nutrition your body can’t fight off bacteria and viruses as well putting you at a much greater risk of getting sick.

Foods to boost your immune system:

1) Protein: our bodies are made up of protein and in the every day wear and tear we need to keep up adequate protein intake to help our bodies re-build tissues and cells. Good sources of protein include lean meats, eggs, beans, and healthy soy products like tempeh.


2) Vitamin C: everyone knows that Vitamin C is essential to a good immune system; this is why it is frequently taken by people at the first sign of a cold. The problem is that people don’t get enough day to day and it is not stored in the body so when your stores are depleted your immune system crashes. Make sure to get Vitamin C in the foods you eat every day to keep your immune system running strong all the time. Good sources of Vitamin C include citrus fruits, bell peppers, berries, broccoli, tomatoes, and even potatoes.


3) Garlic: garlic is antimicrobial, antiviral, and antiparasitic. It is a wonderful immune enhancer. If you don’t like the taste of garlic, or don’t like smelling like garlic then take it in supplement form. Many supplements out there don’t have a taste or smell. Kyloic aged garlic extract is a great supplement.


4) Probiotics: probiotics keep our gastrointestinal (GI) system working properly. Sixty percent of our immune system lies within our GI tract, thus a healthy GI means healthy immunity. The overuse of antibiotics kills off our natural healthy gut flora and lowers our immunity, ironically. Supplementing with probiotics builds this healthy flora back up. Probiotics can be found in yogurt, fermented foods like sauerkraut and pickles, and in supplemental form.



Including these foods in your daily diet will enhance your immunity and protect you from colds and flu. The swine flu is a very real problem in our society right now and it is important to protect ourselves in the best way possible. Good nutrition is always a win-win situation for our health and the health of our families.


source